Obesity Care in Adolescents: Are We Screening for Comorbidities and Providing Anti Obesity Medications? | Pediatrics | American Academy of Pediatrics

Arek Hidirsah, Juan C. Espinoza; Obesity Care in Adolescents: Are We Screening for Comorbidities and Providing Anti Obesity Medications?. Pediatrics February 2022; 149 (1 Meeting Abstracts February 2022): 231. Download citation file: Background: In the United States, obesity impacts the health of over 20% of adolescents. As more data emerges on obesity and the associated adipose tissue dysfunction, updated screening and treatment guidelines for obesity and its related comorbidities have been published. (See Table 1). However, it is unclear if providers are adhering to these guidelines. Methods: We leveraged the TriNetX Research Network platform, a global federated network of electronic medical record data, to identify current national practice patterns for screening for lipid dysfunction, liver function abnormalities, and insulin resistance, and prescribing of anti-obesity medications. Additionally, we reviewed the prescription patterns of FDA approved and off-label anti-obesity medic

Arek Hidirsah, Juan C. Espinoza; Obesity Care in Adolescents: Are We Screening for Comorbidities and Providing Anti Obesity Medications?. Pediatrics February 2022; 149 (1 Meeting Abstracts February 2022): 231. Download citation file: Background: In the United States, obesity impacts the health of over 20% of adolescents. As more data emerges on obesity and the associated adipose tissue dysfunction, updated screening and treatment guidelines for obesity and its related comorbidities have been published. (See Table 1). However, it is unclear if providers are adhering to these guidelines. Methods